Perdichizzi G, Cucinotta D, Fera R, Di Cesare E, Campo S, Squadrito G
Acta Diabetol Lat. 1987 Apr-Jun;24(2):149-55. doi: 10.1007/BF02742853.
Different kidney diseases are often associated with high urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG), a lysosomal enzyme involved in the breakdown of glycoproteins, whose activity is also increased in diabetic patients with poor metabolic control or vascular complications. In order to evaluate the relationship between renal function and urinary NAG levels in diabetes mellitus, 30 type II diabetic patients without evidence of kidney disease and 18 control subjects were studied. In each subject 24-h urinary excretion rates of NAG (fluorimetric method), albumin and beta 2-microglobulin (radioimmunoassay), together with 51Cr-EDTA clearance were performed. In diabetic patients urinary levels of NAG (356 +/- 25 vs 162 +/- 9.2 nmol/h/mg creatinine, p less than 0.0001) and albumin (21 +/- 2.5 vs 4.3 +/- 0.5 mg/24h, p less than 0.0001) were significantly higher than in the controls, while beta 2-microglobulin levels and 51Cr-EDTA clearance did not differ in the two groups. Moreover in diabetic patients NAG and albumin levels were positively and significantly correlated (r = 0.63, p less than 0.001). These results suggest that urinary NAG excretion rate may be altered early in diabetic patients with apparently normal renal function; its diagnostic value seems to be similar to that of the albumin excretion rate.
不同的肾脏疾病常伴有N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)尿排泄增加,NAG是一种参与糖蛋白分解的溶酶体酶,在代谢控制不佳或有血管并发症的糖尿病患者中其活性也会升高。为了评估糖尿病患者肾功能与尿NAG水平之间的关系,对30例无肾脏疾病证据的II型糖尿病患者和18名对照者进行了研究。对每位受试者进行了NAG(荧光法)、白蛋白和β2 - 微球蛋白(放射免疫分析法)的24小时尿排泄率检测,以及51Cr - EDTA清除率检测。糖尿病患者的尿NAG水平(356±25 vs 162±9.2 nmol/h/mg肌酐,p<0.0001)和白蛋白水平(21±2.5 vs 4.3±0.5 mg/24小时,p<0.0001)显著高于对照组,而两组的β2 - 微球蛋白水平和51Cr - EDTA清除率无差异。此外,糖尿病患者中NAG和白蛋白水平呈显著正相关(r = 0.63,p<0.001)。这些结果表明,在肾功能明显正常的糖尿病患者中,尿NAG排泄率可能早期就发生改变;其诊断价值似乎与白蛋白排泄率相似。